| Titre : | Advances in inflammatory myopathies |
| Revue : | Avancées de la recherche |
| Auteurs : | Myoinfo, Auteur ; Benveniste O, Validateur ; Lorain S, Validateur ; Launay AE, Validateur |
| Type de document : | Publication AFM |
| Editeur : | AFM-TELETHON, 06/2022 |
| Collection : | Savoir & Comprendre |
| Pages : | 50 p |
| Langues: | Anglais |
| Mots-clés : | COVID-19 ; dermatomyosite ; diagnostic ; essai clinique ; myopathie nécrosante à médiation autoimmune ; myosite ; myosite à inclusions ; pharmacothérapie ; polymyosite ; respiration (macroscopique) ; thérapie cellulaire ; thérapie génique |
| Résumé : |
Inflammatory myopathies (or myositis) are diseases that involve muscle inflammation. These so-called "autoimmune" diseases are not hereditary. They are characterised by muscle weakness (ranging from simple discomfort to complete paralysis), and often by muscle pain. Certain forms of myositis are accompanied by joint pain or skin manifestations, or even cardiac and/or pulmonary involvement, making these conditions very serious. This document, published to coincide with the AFM-Téléthon General Meeting 2022, presents research news from the past year regarding inflammatory myopathies, such as ongoing studies or clinical trials, scientific and medical publications, etc.
> dermatomyositis (DM) > polymyositis (PM) > inclusion body myositis (IBM) > overlap myositis > antisynthetase syndrome > immune-mediated necrotising myopathy |
Documents numériques (1)
 AV22_MINFL_not75517_202206_eng.pdf Adobe Acrobat PDF |